Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-01-15
1998-12-22
Fitzgerald, David L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514150, 514477, 514483, 514562, 514563, 514596, 514597, 514598, 514617, 514618, 514619, 514708, 514762, 514866, A61K 3105, A61K 3110, A61K 3117, A61K 31655
Patent
active
058519882
ABSTRACT:
Modulation of the activity of the insulin receptor, enhancement of glucose uptake by cells, and other effects significant in the control and management of diabetes are accomplished using compounds of the formula ##STR1## wherein
REFERENCES:
Brinkworth, R.I. et al. "Non-Peptidic Anti-AIDS Agents: Inhibition of HIV-1 proteinase by Disulfonates," Biochemical and Biophysical Research Communities (1992) 188(2):624-630.
Kirchberger, J. et al. "Studies of the interaction of NADH oxidase from Thermus thermophilis HB8 with triazine dyes," Journal of Chromatography A (1994) 668:153-164.
Kletzien, R.F. et al. "Enhancement of Adipocyte Differentiation by an Insulin-Sensitizing Agent," Molecular Pharmacology (1991) 41:393-398.
Kobayashi, M. et al. "Pioglitazone Increases Insulin Sensitivity by Activating Insulin Receptor Kinase," Diabetes (1992) 41:476-483.
Kauvar Lawrence M.
Spevak Wayne R.
Sportsman Richard
Villar Hugo O.
Fitzgerald David L.
Pak Michael
Terrapin Technologies, Inc.
LandOfFree
Nonpeptide insulin receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nonpeptide insulin receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonpeptide insulin receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2047715